3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Papillomavirus Infections
3
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Interventions
Papillomavirus Vaccines
2
Imiquimod
2
GX-188 vaccine
2
Celecoxib
2
4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone
2
poly(gamma-glutamic acid)
1
pembrolizumab
1
nimotuzumab
1
epigallocatechin gallate
1
artesunic acid
1
artemisinin
1
Sutures
1
Progesterone
1
Pemetrexed
1
Omeprazole
1
Ointments
1
Ocoxin
1
Nelfinavir
1
Lighting
1
Indomethacin
1
IRX 2
1
Hepatitis B Vaccines
1
Geritol
1
GPI0100
1
Folic Acid
1
Eflornithine
1
Cyclophosphamide
1
Conization
1
Cisplatin
1
Chemoprevention
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Uterine Cervical Dysplasia
×
artesunic acid
×
Clear all
NCT04098744
2025-10-02
ART-CIN_IIB
Frantz Viral Therapeutics, LLC
Phase 2
Recruiting
78 enrolled